glp-1 microdosing for weight loss GLP-1s: Risks & Considerations Microdosing GLP-1s: Does It Work?

doi: 10.1515/BC.2008.019

High-resolution quantitative computed tomography demonstrates structural defects in cortical and trabecular bone in IBD patients

Semaglutide is typically titrated up to 2.4mg weekly for weight loss

May administer without regard to food Kidney disease No dose adjustment is necessary for any degree of renal impairment Liver disease No dose adjustment is necessary for any degree of hepatic impairment Generic / Price NO/$$$$ Storage Unused pens Keep refrigerated Good until expiration date Do not freeze After first dose Store at room temperature or refrigerated Good for 56 days Semaglutide Rybelsus Rybelsus Dosage forms Tablet (formulation R1) 3 mg 7 mg 14 mg Tablet (formulation R2) 1.5 mg 4 mg 9 mg Dosing Type 2 diabetes (formulation R1) Starting (Day 1 to 30): 3 mg once daily for 30 days (this dosage is not effective for glycemic control) Escalation and Maintenance Dosage: Days 31 to 60: Increase the dosage to 7 mg orally once daily Day 61 and on: If blood sugars are controlled, continue 7 mg once daily

The SeekPeptides reconstitution and storage guides walk through each step with visual instructions that eliminate the guesswork

SURPASS-2 (n=1,879): This head-to-head trial compared tirzepatide (Mounjaro) against semaglutide (Ozempic) in adults with type 2 diabetes